Ameet Nathwani, Dewpoint CEO (Viva Technology/Sipa/L.Chamussy, Sipa via AP Images)
SoftBank leads $150M round into Dewpoint as condensate biotech nears clinic
In another market, Dewpoint Therapeutics may have gone public about now and raised a princely sum.
Although they’re still around two years from human trials …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
